Gastroenterology Private Equity: Should You Sell?
Gastroenterology private equity activity has reached many independent GI groups over the past decade, and owners who have not yet received an offer often expect one. For partners, the decision is rarely just about price. A sale can bring liquidity and administrative support, while independence can preserve control over compensation, ancillaries and the culture the group has built.
This article outlines how these transactions generally work, what owners give up and gain, and what alternatives exist. Every transaction is different, ownership and structuring rules vary by state, and nothing here is legal, tax, investment or compliance advice. Owners should involve healthcare counsel, accountants and other qualified advisors before signing anything.
Why Gastroenterology Private Equity Interest Has Grown
GI has several characteristics that attract investors:
- Steady demand for screening and diagnostic procedures, supported by expanded screening guidelines
- Ancillary income from endoscopy centers, anesthesia, pathology and infusion
- A fragmented market in which many practices are small, physician-owned groups
- A shortage of gastroenterologists in many regions, which can support volume
Investors typically form a platform by acquiring a large regional group, then add smaller practices over time. Only a portion of gastroenterologists practice in investor-backed groups, so many owners are still deciding which path to take.
How a Typical Transaction Is Structured
Structures vary, but many deals share common elements:
- Purchase of non-clinical assets: in many states, a management company acquires the business side of the practice, while a physician-owned entity continues to provide care, subject to state law
- Upfront cash: paid to selling physicians at closing
- Rollover equity: physicians reinvest part of their proceeds in the platform
- Compensation reset: physicians accept lower ongoing compensation in exchange for the purchase price
- Employment and restrictive covenants: multi-year commitments and non-compete terms
The compensation reset is often the most important term. The purchase price is largely funded by the portion of income physicians agree to give up going forward. Our article on GI rollover equity explains how the reinvested portion works.
Potential Benefits of Selling
- Liquidity for senior partners nearing retirement
- Reduced administrative burden and access to shared management resources
- Capital for new sites, centers or technology
- Potential upside if rollover equity increases in value
- Negotiating leverage with payers through scale, depending on the market
Potential Drawbacks
- Permanently lower compensation after the reset
- Reduced control over staffing, scheduling, ancillaries and strategy
- Restrictive covenants that may limit future options
- Uncertainty about the value and timing of rollover equity
- Generational tension, as younger physicians may bear the reset for longer than senior partners who receive most of the proceeds
That last point is often decisive. A transaction that works well for a partner nearing retirement may look very different to an associate who will practice for decades under the new compensation model.
Questions to Ask Before Signing a Letter of Intent
- What exactly is being purchased, and what remains with the physicians?
- How is the post-sale compensation formula calculated, and can it change?
- How much of the price is cash at closing, rollover equity or contingent payments?
- What happens to endoscopy center and real estate interests?
- What are the terms for physicians who leave, retire or become disabled?
- How will associates and future hires be treated?
Owners should also obtain an independent view of value. Our article on gastroenterology practice valuation explains the main drivers.
What Happens to Ancillaries and Real Estate
Endoscopy center interests are often a large part of what investors want. Some transactions include the physicians’ center shares in the sale, while others leave them partly in physician hands or restructure them. Owners should understand exactly how center distributions will be shared after closing and whether hospital or other partners in the center have consent rights.
Real estate is frequently handled separately. Physicians who own the building may keep it and sign a new lease with the platform, or sell it to a separate buyer. The lease terms can affect both rental income and the value of the property, so they deserve the same attention as the practice sale itself.
Alternatives to Selling
Selling to an investor is one of several options. Others include:
- Internal succession: younger partners buy out senior partners over time
- Sale to another physician or group: a physician-to-physician transaction
- Merger with other independent groups: gaining scale without outside ownership
- Bank recapitalization: borrowing against the practice’s cash flow to provide partial liquidity while physicians retain ownership
Our guide to an alternative to private equity for GI groups explains how a recapitalization may work. For larger groups, middle-market healthcare financing may support recapitalizations, partner buyouts and growth while keeping ownership with physicians. Every loan is subject to approval.
Owners comparing these paths may also find our article on gastroenterology succession planning helpful.
Making the Decision
There is no single right answer. Groups that decide to sell often do so because partners want liquidity and are comfortable with less control. Groups that remain independent often value autonomy and believe their own cash flow can fund growth and transitions.
Whichever path you choose, the process works best when every partner understands the economics, including how the compensation reset and rollover equity affect each physician over time. Our advisory and consulting services can help owners evaluate options and prepare for a transaction.
Final Thoughts
Gastroenterology private equity offers can provide meaningful liquidity, but they also change how physicians are paid and how decisions are made. Comparing offers with independent alternatives, and understanding each term in detail, can help partners choose the path that fits the whole group.
US Medical Funding helps independent GI groups finance recapitalizations, partner buyouts and growth. Learn more about our gastroenterology practice financing options.
